Trials / Completed
CompletedNCT00212719
Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 250 (planned)
- Sponsor
- Ono Pharmaceutical Co., Ltd. · Industry
- Sex
- Female
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of ONO-5920 in patients with involutional osteoporosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ONO-5920 |
Timeline
- Start date
- 2003-05-01
- Primary completion
- 2006-04-01
- First posted
- 2005-09-21
- Last updated
- 2012-10-11
Source: ClinicalTrials.gov record NCT00212719. Inclusion in this directory is not an endorsement.